| 注册
首页|期刊导航|中国老年保健医学|紫杉醇脂质体联合卡培他滨治疗晚期胃癌临床观察

紫杉醇脂质体联合卡培他滨治疗晚期胃癌临床观察

陆明洁 王建 刘平 束永前

中国老年保健医学Issue(6):9-11,12,4.
中国老年保健医学Issue(6):9-11,12,4.DOI:10.3969/j.issn.1672-4860.2013.06.003

紫杉醇脂质体联合卡培他滨治疗晚期胃癌临床观察

Clinical observation of paclitaxel liposome combined with capecitabine in the treatment of advanced gastric cancer

陆明洁 1王建 1刘平 1束永前1

作者信息

  • 1. 江苏省人民医院 肿瘤科 210029
  • 折叠

摘要

Abstract

Objective To evaluate the efficacy and toxic side effects of paclitaxel liposome combined with capecitabine for trea -ting 34 patients with advanced gastric cancer.Methods A total of 64 patients with advanced gastric cancer were enrolled and as-signed to experimental group (paclitaxel liposome combined with capecitabine as PC regimen ,34 cases) and control group (docetax-el,cisplatin and 5-fluorouracil as DCF regimen,30 cases).Control group was treated with DCF regimen:docetaxel 75mg/m2,d1, cisplatin 20mg/m2 ,d1~5 and 5-fluorouracil 350mg/m2 ,d1~5,21d/cycle.Experimental group was given PC regimen:paclitaxel liposome 135mg/m2,d1;capecitabine 2000mg/(m2· d),po,bid,d1~14,21d/cycle.Results Control group:the total chemothera-py time was 122 cycles,averagely 4.07 cycles.Two patients got complete remission (CR),12 partial remission (PR),7 stable dis-ease (SD) and 9 progressive disease (PD).The short -term response rate (RR) was 46.7%,disease control rate (DCR) was 70%,median progression free survival ( mPFS) was 6.9 months and median overall survival ( mOS) was 12.5 months.Experimental group:the total chemotherapy time was 169 cycles,averagely 4.97 cycles.Fourteen patients got PR,9 SD and 11 PD.The short -term RR was 41.2%,DCR was 67.6%,mPFS was 6.2 months and mOS was 12 months.There were no significant differences re-garding RR,DCR,progression -free survival curves and overall survival curves of two groups.The major toxic side effects of two groups are hematologic toxicities.The incidences of leukopenia and anemia at grades Ⅲ~Ⅳin control group and experimental group were 56.7%and 17.6%as well as 13.3%and 2.9%,respectively.Conclusion Paclitaxel liposome combined with capecitabine as the first line chemotherapy for advanced gastric cancer is effective ,tolerable,and recommendable.

关键词

晚期胃癌/药物疗法/紫杉醇脂质体/卡培他滨

Key words

advanced gastric carcinoma/drug therapy/paclitaxel liposome/capecitabine

引用本文复制引用

陆明洁,王建,刘平,束永前..紫杉醇脂质体联合卡培他滨治疗晚期胃癌临床观察[J].中国老年保健医学,2013,(6):9-11,12,4.

基金项目

中国高校医学期刊临床专项资金 ()

中国老年保健医学

1672-2671

访问量0
|
下载量0
段落导航相关论文